Cite
HARVARD Citation
Schiff, M. et al. (2014). Head-to-head comparison of subcutaneous abatacept versus adalimumab for rheumatoid arthritis: two-year efficacy and safety findings from AMPLE trial. Annals of the rheumatic diseases. 73 (1), pp. 86-94. [Online].